Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study
โ Scribed by Meri P. Nantz; Cheryl A. Rowe; Jack F. Bukowski; Susan S. Percival
- Book ID
- 113828857
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 218 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0899-9007
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Objective To conduct a robust, doubleโblind, placeboโcontrolled study examining the effects of tumor necrosis factor (TNF) modulation on concentrations of traditional and novel cardiovascular disease risk factors in patients with an inflammatory condition. ## Methods In this doubl
## Abstract ## Objectives To compare the efficacy, safety and tolerability of a novel rivastigmine transdermal patch with conventional rivastigmine capsules and placebo in patients with Alzheimer's disease (AD). ## Methods In this 24โweek, multicenter, doubleโblind, doubleโdummy, placeboโ and ac